Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Henning T. Mouridsen
Sign up to set email alerts
487
Publications
10,963
Citation Statements Received
4,654
Citation Statements Given
How they've been cited
20,668
471
10,408
84
How they cite others
10,357
314
4,250
90
Affiliations
Rigshospitalet
,
Danish Breast Cancer Cooperative Group
Publications
Order By: Most citations
Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy
Overgaard
1
,
Hansen
2
,
Overgaard
3
et al.
1997
N Engl J Med
Abstract
Show
2,529
37
1,088
8
Get access via publisher
Add to collection
Cite
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial
Overgaard
1
,
Jensen
2
,
Overgaard
3
et al.
1999
The Lancet
1,593
29
715
2
Get access via publisher
Add to collection
Cite
Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98
Coates
1
,
Keshaviah
2
,
Thurlimann
3
et al.
2007
JCO
Abstract
Show
890
20
534
4
Get access via publisher
Add to collection
Cite
Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group
Mouridsen
1
,
Gershanovich
2
,
Sun
3
et al.
2001
JCO
Abstract
Show
1,000
14
483
3
3
Get access via publisher
Add to collection
Cite
Phase III Study of Letrozole Versus Tamoxifen as First-Line Therapy of Advanced Breast Cancer in Postmenopausal Women: Analysis of Survival and Update of Efficacy From the International Letrozole Breast Cancer Group
Mouridsen
1
,
Gershanovich
2
,
Sun
3
et al.
2003
JCO
Abstract
Show
757
14
397
1
Get access via publisher
Add to collection
Cite
Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study
Van Glabbeke
1
,
van Oosterom
2
,
Oosterhuis
3
et al.
1999
JCO
Abstract
Show
572
22
319
7
Get access via publisher
Add to collection
Cite
Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Santoro
1
,
Tursz
2
,
Mouridsen
3
et al.
1995
JCO
Abstract
Show
518
5
287
1
Get access via publisher
Add to collection
Cite
Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients
Grøenvold
1
,
Petersen
2
,
Idler
3
et al.
2007
Breast Cancer Res Treat
Abstract
Show
370
12
254
5
Get access via publisher
Add to collection
Cite
1
2
3